Intervention

Buprenorphine

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 18 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18
Recruiting2
Common conditions21
Lead sponsors shown15
Advertisement

Clinical trials

18 shown
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive EpisodeNCT03646058 · 2021-10-10
RECRUITING
Bariatric Surgery and Pharmacokinetics of BuprenorphineNCT03460314 · 2016-11-02
RECRUITING
Rapid Antidepressant Improvement Secondary to Excitatory Brain ResponsesNCT04276259 · 2020-10-19
COMPLETED
Opiate Suicide Study in Patients With Major DepressionNCT04116528 · 2020-08-01
COMPLETED
Onsite Buprenorphine Treatment at Syringe Exchange ProgramsNCT03150173 · 2019-01-02
COMPLETED
Buprenorphine Group Medical Visits in Primary CareNCT02526212 · 2017-01-01
COMPLETED
Incomplete Response in Late-Life Depression: Getting to Remission With BuprenorphineNCT02176291 · 2014-08-01
COMPLETED
Efficacy of Pain Treatment on Depression in Patients With DementiaNCT02267057 · 2014-08-01
COMPLETED
Neurocognitive Effects of Opiate Agonist TreatmentNCT01733693 · 2013-01-01
COMPLETED
Diversion to Treatment for Injection Drug Users Arrested for Possession of HeroinNCT01723527 · 2012-12-01
COMPLETED
Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD PatientsNCT01311570 · 2012-10-01
UNKNOWN
Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for ProstitutionNCT01560221 · 2012-10-01
COMPLETED
Buprenorphine for Treatment Resistant DepressionNCT01407575 · 2011-09-01
COMPLETED
Buprenorphine for Late-Life Treatment Resistant DepressionNCT01071538 · 2010-05-01
COMPLETED
Relapse Prevention to Reduce HIV Among Women PrisonersNCT00763958 · 2008-05-01
COMPLETED
Interaction of Buprenorphine With HIV Medications and Tuberculosis MedicationsNCT00877591 · 2008-04-01
COMPLETED
Buprenorphine and Integrated HIV Care EvaluationNCT00124358 · 2005-08-01
UNKNOWN
Project BEST: Buprenorphine Entry Into Substance Abuse TreatmentNCT02583243 · 2005-05-01
COMPLETED

Trial status mix

COMPLETED14
RECRUITING2
UNKNOWN2

Phase mix

PHASE45
PHASE14
PHASE34
PHASE23
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.